Philotypes of intestinal microbiotes in patients with arterial hypertension and abdominal obesity
DOI:
https://doi.org/10.14739/2310-1237.2020.3.221771Keywords:
arterial hypertension, abdominal obesity, gut microbiota, phylotypesAbstract
The aim: to study the content of the main phylotypes of the gut microbiota (GM) (Firmicutes, Bacteroidetes and Actinobacteria) in residents of Ukraine – patients with arterial hypertension (AH), which occurs against the background of abdominal obesity (AO) and metabolic disorders.
Materials and methods. 70 patients (residents of Ukraine) with AH stage II, 2–3 degrees (46 patients with AO and 24 with normal body weight (NBW)) were examined. The control group consisted of 20 practically healthy individuals. The survey included standard clinical, laboratory and instrumental methods. The content of the main GM phylotypes was determined by identifying the total bacterial DNA and DNA of Firmicutes, Bacteroidetes and Actinobacteria using the method of quantitative real-time polymerase chain reaction. Statistical analysis of the data was carried out using standard methods using Microsoft Excel 17.0.
Results. In patients with AH in combination with AO, residents of Ukraine, significant differences were revealed in the relative content of the main phylotypes of GM, both in comparison with healthy individuals and patients with AH and NBW: a significant increase in the relative content of Firmicutes compared with the control group and a significant increase in the ratio of Firmicutes/Bacteroidetes in comparison with practically healthy individuals and with hypertension patients with NBW. In addition, in AH patients with AO, in contrast to AH patients with NBW, it was found that changes in the GM composition at the level of their main phylotypes are associated with the presence of prediabetes, an insulin resistance (IR) index, and the level of low-density lipoprotein cholesterol in the blood.
Conclusions. The results of this study indicate that changes in GM can play a significant role in the pathogenesis of AH and AO in residents of Ukraine.
References
NCD Risk Factor Collaboration (NCD-RisC) (2017). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19•1 million participants. Lancet, 389(10064), 37-55. https://doi.org/10.1016/S0140-6736(16)31919-5
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E, Azizi, M., Burnier, M.,… Desormais, I. (2018). 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). European Heart Journal, 39(33), 3021-3104. http://doi.org/10.1093/eurheartj/ehy339
Redon, J., Martinez, F. & Pichler, G. (2019). The metabolic syndrome in hypertension. In G. Mancia, G. Grassi, K. P.Tsioufis, A. F. Dominiczak, & E. Agabiti Rosei (Eds.), Manual of Hypertension of the European Society of Hypertension (3rd ed., pp. 135-148). Press Taylor & Francis Group. https://doi.org/10.1201/9780429199189
Hall, M. E., & Hall, J. E. (2018). Pathogenesis of hypertension. In G. L. Bakris, M. J. Sorrentino (Eds.), Hypertension: A Companion to Braunwald's Heart Disease. (3rd ed., pp. 33-52). Elsevier.
Koval, S., Iushko, K., & Starchenko, T. (2018). Relations of Apelin with Cardiac Remodeling in Patients with Hypertension and Type 2 Diabetes. Folia medica, 60(1), 117-123. https://doi.org/10.1515/folmed-2017-0066
Koval, S. M., Yushko, K. O., Snihurska, I. O., Starchenko, T. G., Pankiv, V. I., Lytvynova, O. M., & Mysnychenko, O. V. (2019). Relations of angiotensin-(1-7) with hemodynamic and cardiac structural and functional parameters in patients with hypertension and type 2 diabetes. Arterial hypertension, 23(3), 183-189. http://doi.org/10.5603/AH.a2019.0012
Koval, S., Snihurska, I., Yushko, K., Lytvynova, O., & Berezin, A. (2019). Plasma microRNA-133а level in patients with essential arterial hypertension. Georgian medical news, (290), 52-59.
Koval, S. M., Snihurska, I. O., Yushko, K. O., Mysnychenko, O. V., Penkova, M. Y., Lytvynova, O. M., Berezin, A. E., & Lytvynov, V. S. (2020). Circulating microRNA-133a in Patients With Arterial Hypertension, Hypertensive Heart Disease, and Left Ventricular Diastolic Dysfunction. Frontiers in cardiovascular medicine, 7, 104. https://doi.org/10.3389/fcvm.2020.00104
Kazemian, N., Mahmoudi, M., Halperin, F., Wu, J. C., & Pakpour, S. (2020). Gut microbiota and cardiovascular disease: opportunities and challenges. Microbiome, 8(1), 36. https://doi.org/10.1186/s40168-020-00821-0
Katsimichas, T., Antonopoulos, A. S., Katsimichas, A., Ohtani, T., Sakata, Y., & Tousoulis, D. (2019). The intestinal microbiota and cardiovascular disease. Cardiovascular research, 115(10), 1471-1486. https://doi.org/10.1093/cvr/cvz135
Fadieienko, G. D., Gridnyev, O. Y., Chereliuk, N. I., & Kurinna, O. G. (2019). Rol kishechnoi mikrobioty v razvitii nealkogol'noi zhirovoi bolezni pecheni [The role of intestinal microbiome in the progression of non-alcoholic fatty liver disease]. Suchasna hastroenterolohiia, (4), 92-99. [in Russian].
Koval, S. M., Yushko, K. O., & Snihurska, I. O. (2020). Kyshkova mikrobiota ta arterialna hipertenziia (ohliad literatury). [Gut microbiota and hypertension (a literature review]. Zaporozhye medical journal, 22(4), 561-567. [in Ukrainian]. https://doi.org/10.14739/2310-1210.2020.4.208409
Oyama, J. & Node, K. (2019). Gut microbiota and hypertension. Hypertens Res, 42, 741-743. http://doi.org/10.1038/s41440-018-0203-5
Kang, Y., & Cai, Y. (2018). Gut microbiota and hypertension: From pathogenesis to new therapeutic strategies. Clinics and research in hepatology and gastroenterology, 42(2), 110-117. https://doi.org/10.1016/j.clinre.2017.09.006
Magne, F., Gotteland, M., Gauthier, L., Zazueta, A., Pesoa, S., Navarrete, P., & Balamurugan, R. (2020). The Firmicutes/Bacteroidetes Ratio: A Relevant Marker of Gut Dysbiosis in Obese Patients?. Nutrients, 12(5), 1474. https://doi.org/10.3390/nu12051474
Kovalenko, V. M. Lutai, M. I., Sirenko, Yu. M., & Sychov, O. S. (Eds.). (2020). Certsevo-sudynni zakhvoriuvannia. Klasyfikatsiia, standarty diahnostyky ta likuvannia [Cardiovascular diseases. Classification, standards of diagnosis and treatment] (4th ed.). MORION. [in Ukrainian].
Obesity: preventing and managing the global epidemic. Report of a WHO consultation. (2000). World Health Organization technical report series, 894, i-253.
Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., ... Wheeleret, D. C. (2020). 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD). European Heart Journal, 41(2), 255-323. https://doi.org/10.1093/eurheartj/ehz486
Sun, S., Lulla, A., Sioda, M., Winglee, K., Wu, M. C., Jacobs, D. R., Jr, Shikany, J. M., Lloyd-Jones, D. M., Launer, L. J., Fodor, A. A., & Meyer, K. A. (2019). Gut Microbiota Composition and Blood Pressure. Hypertension, 73(5), 998-1006. https://doi.org/10.1161/HYPERTENSIONAHA.118.12109
Mushtaq, N., Hussain, S., Zhang, S., Yuan, L., Li, H., Ullah, S., Wang, Y., & Xu, J. (2019). Molecular characterization of alterations in the intestinal microbiota of patients with grade 3 hypertension. International journal of molecular medicine, 44(2), 513-522. https://doi.org/10.3892/ijmm.2019.4235
Yang, T., Santisteban, M. M., Rodriguez, V., Li, E., Ahmari, N., Carvajal, J. M., Zadeh, M., Gong, M., Qi, Y., Zubcevic, J., Sahay, B., Pepine, C. J., Raizada, M. K., & Mohamadzadeh, M. (2015). Gut dysbiosis is linked to hypertension. Hypertension, 65(6), 1331-1340. https://doi.org/10.1161/HYPERTENSIONAHA.115.05315
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006). Microbial ecology: human gut microbes associated with obesity. Nature, 444(7122), 1022-1023. https://doi.org/10.1038/4441022a
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., Egholm, M., Henrissat, B., Heath, A. C., Knight, R., & Gordon, J. I. (2009). A core gut microbiome in obese and lean twins. Nature, 457(7228), 480-484. https://doi.org/10.1038/nature07540
Duncan, S. H., Lobley, G. E., Holtrop, G., Ince, J., Johnstone, A. M., Louis, P., & Flint, H. J. (2008). Human colonic microbiota associated with diet, obesity and weight loss. International journal of obesity, 32(11), 1720-1724. https://doi.org/10.1038/ijo.2008.155
Santacruz, A., Marcos, A., Wärnberg, J., Martí, A., Martin-Matillas, M., Campoy, C., Moreno, L. A., Veiga, O., Redondo-Figuero, C., Garagorri, J. M., Azcona, C., Delgado, M., García-Fuentes, M., Collado, M. C., Sanz, Y., & EVASYON Study Group (2009). Interplay between weight loss and gut microbiota composition in overweight adolescents. Obesity, 17(10), 1906-1915. https://doi.org/10.1038/oby.2009.112
Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N. A., Donus, C., & Hardt, P. D. (2010). Microbiota and SCFA in lean and overweight healthy subjects. Obesity, 18(1), 190-195. https://doi.org/10.1038/oby.2009.167
Allin, K. H., Tremaroli, V., Caesar, R., Jensen, B., Damgaard, M., Bahl, M. I., Licht, T. R., Hansen, T. H., Nielsen, T., Dantoft, T. M., Linneberg, A., Jørgensen, T., Vestergaard, H., Kristiansen, K., Franks, P. W., IMI-DIRECT consortium, Hansen, T., Bäckhed, F., & Pedersen, O. (2018). Aberrant intestinal microbiota in individuals with prediabetes. Diabetologia, 61(4), 810-820. https://doi.org/10.1007/s00125-018-4550-1
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., … Pedersen, O. (2013). Richness of human gut microbiome correlates with metabolic markers. Nature, 500(7464), 541-546. https://doi.org/10.1038/nature12506
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
